Volume 67, Issue 5, Pages (May 2005)

Slides:



Advertisements
Similar presentations
2016 Annual Data Report, Vol 2, ESRD, Ch 5
Advertisements

Stephen P. McDonald, Graeme R. Russ  Kidney International 
Figure 1.1 Prevalence of CKD by stage among NHANES participants,
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Table 6.1 Prevalent Medicare fee-for-service patient counts and spending for beneficiaries aged 65 and older, by DM, CHF, and/or CKD, 2014 U.S. Medicare.
Robert C. Stanton, MD  American Journal of Kidney Diseases 
Chapter 2: Identification and Care of Patients With CKD
2017 Annual Data Report Healthy People 2020.
Chapter 6: Health Expenditures for Persons with CKD
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Chapter 1: CKD in the General Population
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
2016 Annual Data Report, Vol 2, ESRD, Ch 4
Volume 1: Chronic Kidney Disease Chapter 3: Morbidity and Mortality
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh  Kidney International 
Diabetic Kidney Disease: An ACEI (or an ARB) in the Hole
2018 Annual Data Report Volume 3: Healthy People 2020
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
Volume 83, Issue 3, Pages (March 2013)
Volume 92, Issue 1, Pages (July 2017)
Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh  Kidney International 
Volume 72, Issue 5, Pages (September 2007)
Volume 57, Issue 5, Pages (May 2000)
Chapter 7: Healthcare Expenditures for Persons with CKD
Mortality caused by sepsis in patients with end-stage renal disease compared with the general population  Mark J. Sarnak, Bertrand L. Jaber  Kidney International 
Burden of chronic kidney disease: North Africa
Andrew Narva  American Journal of Kidney Diseases 
Francesco Paolo Schena  Kidney International 
Need for better diabetes treatment for improved renal outcome
End-stage renal disease in living kidney donors
Volume 63, Issue 2, Pages (February 2003)
C.Y. Hsu, J.D. Ordoñez, G.M. Chertow, D. Fan, C.E. McCulloch, A.S. Go 
Volume 72, Issue 9, Pages (November 2007)
Robert C. Stanton, MD  American Journal of Kidney Diseases 
Anemia as a risk factor for chronic kidney disease
Survival advantage in Asian American end-stage renal disease patients1
Manjula Kurella Tamura, Kristine Yaffe  Kidney International 
Kamila Czene, Ph.D., Kari Hemminki  Kidney International 
Fernando Valderrábano, Francisco Gómez-Campderá, Elizabeth H.P. Jones 
The epidemiology of chronic kidney disease
Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study  Eric D.
Volume 70, Issue 12, Pages (December 2006)
American Journal of Kidney Diseases
Cardiovascular disease in pediatric chronic dialysis patients
Racial disparities in access to transplantation: a tough nut to crack
V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen 
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Transforming growth factor beta and progression of renal disease
Arjang Djamali, Christina Kendziorski, Peter C. Brazy, Bryan N. Becker 
Volume 64, Issue 4, Pages (October 2003)
Prehypertension: is it relevant for nephrologists?
E.A. Friedman, A.L. Friedman, P. Eggers  Kidney International 
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Volume 64, Issue 2, Pages (August 2003)
Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors  Barry M. Brenner, Joann Zagrobelny 
ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: The African American Study of Kidney Disease and Hypertension (AASK) trial 
Unraveling the racial disparities associated with kidney disease1
Volume 76, Issue 6, Pages (September 2009)
Volume 77, Issue 1, Pages (January 2010)
Volume 64, Issue 4, Pages (October 2003)
Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley 
Volume 66, Pages S7-S10 (November 2004)
Giuseppe Remuzzi, Carlos Chiurchiu, Piero Ruggenenti 
Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance1  William M.
Volume 61, Issue 2, Pages (February 2002)
The conundrum of increased burden of end-stage renal disease in Asians
A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan  Yi-Chun.
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Jay S. Kaufman, PhD, Sam Harper, PhD  The American Journal of Medicine 
Presentation transcript:

Volume 67, Issue 5, Pages 1684-1691 (May 2005) Epidemic of end-stage renal disease in people with diabetes in the United States population: Do we know the cause?  Camille A. Jones, Andrzej S. Krolewski, John Rogus, Jay L. Xue, Allan Collins, James H. Warram  Kidney International  Volume 67, Issue 5, Pages 1684-1691 (May 2005) DOI: 10.1111/j.1523-1755.2005.00265.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 The number of individuals initiating treatment for end-stage renal disease (ESRD) in the United States, according to cause and calendar year, 1980 to 1999 (RenDER system of the United States Renal Data System (USRDS) (http://www.usrds.org>). The vertical line A marks the publication of the clinical trial showing the renoprotective effect of angiotensin-converting enzyme (ACE) inhibition15. Abbreviations are: DM, diabetes mellitus; HTN, hypertension; GN, glomerulonephritis. Kidney International 2005 67, 1684-1691DOI: (10.1111/j.1523-1755.2005.00265.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Incidence rates of treated end-stage renal disease (ESRD) attributed to diabetes per 100,000 individuals with diagnosed diabetes in the United States, 1984 to 1996. The vertical line A marks the publication of the clinical trial showing the renoprotective effect of angiotensin-converting enzyme (ACE) inhibition15. Rates are shown separately for non-Hispanic whites (left panel) and non-Hispanic blacks (right panel). For ages <45 years (upper graphs) males and females are shown separately, while for older age groups (lower graphs) the genders were combined since their rates were similar. Data are based on National Health Interview Survey estimates of the number of persons with diabetes and United States Renal Data System (USRDS) data on the number of persons with incident ESRD attributed to diabetes (1999 Diabetes Surveillance Report, http://www.cdc.gov/diabetes/statistics/index.htm). Kidney International 2005 67, 1684-1691DOI: (10.1111/j.1523-1755.2005.00265.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Age-adjusted prevalence of diabetes (diagnosed and undiagnosed) in adults aged 20 years and older in the United States population according to race and time period34. DM is diabetes mellitus. Kidney International 2005 67, 1684-1691DOI: (10.1111/j.1523-1755.2005.00265.x) Copyright © 2005 International Society of Nephrology Terms and Conditions